Literature DB >> 23252485

Genetic variation in the receptor for advanced glycation end-products (RAGE) gene and ischaemic stroke.

S Olsson1, K Jood.   

Abstract

BACKGROUND AND
PURPOSE: The multi-ligand receptor for advanced glycation end-products (RAGE, alias AGER) is suggested to contribute to the pathogenesis of vascular disease, but its potential role in stroke is unclear. The aim of this study was to investigate whether genetic variation in RAGE gene is associated with ischaemic stroke (IS).
METHODS: The Sahlgrenska Academy Study on Ischaemic Stroke comprises 844 Caucasian patients with first ever (n = 732) and recurrent (n = 112) IS, and 668 Caucasian controls. Three tagSNPs were selected to capture genetic variation in the RAGE gene. IS subtypes were determined using TOAST criteria.
RESULTS: One SNP, rs1035798, showed significant association with the subtype of small-vessel disease (SVD) after correction for multiple testing (OR 1.56, 95% CI 1.16-2.09), adjusted P-value < 0.05). This association was independent of hypertension, diabetes and smoking. None of the SNPs was associated with overall IS.
CONCLUSION: In this sample of patients with IS, genetic variation in RAGE is associated with the IS subtype SVD, but not overall IS.
© 2012 The Author(s) European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23252485     DOI: 10.1111/ene.12041

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

1.  Genetic analysis of advanced glycation end products in the DHS MIND study.

Authors:  Jeremy N Adams; Laura M Raffield; Susan E Martelle; Barry I Freedman; Carl D Langefeld; J Jeffrey Carr; Amanda J Cox; Donald W Bowden
Journal:  Gene       Date:  2016-02-23       Impact factor: 3.688

2.  Determinants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancer.

Authors:  Zhigang Duan; Guoqing Chen; Liang Chen; Rachael Stolzenberg-Solomon; Stephanie J Weinstein; Satu Mannisto; Donna L White; Demetrius Albanes; Li Jiao
Journal:  Int J Mol Epidemiol Genet       Date:  2014-10-22

Review 3.  Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism.

Authors:  Marine Serveaux-Dancer; Matthieu Jabaudon; Isabelle Creveaux; Corinne Belville; Raïko Blondonnet; Christelle Gross; Jean-Michel Constantin; Loïc Blanchon; Vincent Sapin
Journal:  Dis Markers       Date:  2019-02-04       Impact factor: 3.434

4.  Association between the Advanced Glycosylation End Product-Specific Receptor Gene and Cardiovascular Death in Older Men.

Authors:  Erik Biros; Corey S Moran; Paul E Norman; Graeme J Hankey; Bu B Yeap; Osvaldo P Almeida; Leon Flicker; Richard White; Rhondda Jones; Jonathan Golledge
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

5.  Polymorphisms in three genes are associated with hemorrhagic stroke.

Authors:  Wenpeng Liu; Shichao Ge; Yan Liu; Can Wei; Yunlong Ding; Aimin Chen; Qiyao Wu; Yuqing Zhang
Journal:  Brain Behav       Date:  2015-10-01       Impact factor: 2.708

6.  Genetic predisposition to ischaemic stroke by RAGE and HMGB1 gene variants in Chinese Han population.

Authors:  You Li; Jing Zhu; Linfa Chen; Weidong Hu; Mengxu Wang; Shengnan Li; Xuefeng Gu; Hua Tao; Bin Zhao; Guoda Ma; Keshen Li
Journal:  Oncotarget       Date:  2017-10-26

7.  Polymorphisms and Gene-Gene Interaction in AGER/IL6 Pathway Might Be Associated with Diabetic Ischemic Heart Disease.

Authors:  Kuo Liu; Yunyi Xie; Qian Zhao; Wenjuan Peng; Chunyue Guo; Jie Zhang; Ling Zhang
Journal:  J Pers Med       Date:  2022-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.